Vitamin D Deficiency Is Associated with Increased Nontuberculous Mycobacteria Risk in Cystic Fibrosis.
作者信息
Richter William J, Sun Yuqing, Psoter Kevin J, Santos Matthew N, Nguyen Jan A, Sidhaye Aniket, Lechtzin Noah, Jennings Mark T, Cohen Keira A
机构信息
Johns Hopkins University School of Medicine Baltimore, Maryland.
出版信息
Ann Am Thorac Soc. 2021 May;18(5):913-916. doi: 10.1513/AnnalsATS.202003-216RL.
Abstract
摘要
相似文献
1
Vitamin D Deficiency Is Associated with Increased Nontuberculous Mycobacteria Risk in Cystic Fibrosis.维生素D缺乏与囊性纤维化患者非结核分枝杆菌感染风险增加有关。
Ann Am Thorac Soc. 2021 May;18(5):913-916. doi: 10.1513/AnnalsATS.202003-216RL.
2
Nontuberculous Mycobacterial Infections in Cystic Fibrosis.囊性纤维化中的非结核分枝杆菌感染
Clin Chest Med. 2016 Mar;37(1):83-96. doi: 10.1016/j.ccm.2015.11.001. Epub 2015 Dec 23.
3
Nontuberculous Mycobacterial Infections in Cystic Fibrosis.囊性纤维化中的非结核分枝杆菌感染
Thorac Surg Clin. 2019 Feb;29(1):95-108. doi: 10.1016/j.thorsurg.2018.09.008.
4
The growing threat of nontuberculous mycobacteria in CF.囊性纤维化中非结核分枝杆菌日益增长的威胁。
J Cyst Fibros. 2015 Jan;14(1):1-2. doi: 10.1016/j.jcf.2014.12.002. Epub 2014 Dec 6.
5
Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy.与变应性支气管肺曲霉病及类固醇治疗相关的囊性纤维化中的非结核分枝杆菌
Eur Respir J. 2005 Feb;25(2):324-8. doi: 10.1183/09031936.05.00058604.
6
Detecting clusters of high nontuberculous mycobacteria infection risk for persons with cystic fibrosis - An analysis of U.S. counties.检测美国县的囊性纤维化患者中非结核分枝杆菌感染风险的聚集簇。
Tuberculosis (Edinb). 2023 Jan;138:102296. doi: 10.1016/j.tube.2022.102296. Epub 2022 Dec 19.
7
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.美国囊性纤维化基金会和欧洲囊性纤维化协会关于囊性纤维化患者非结核分枝杆菌管理的共识建议。
J Cyst Fibros. 2016 Mar;15(2):139-40. doi: 10.1016/S1569-1993(16)00018-7.
8
Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population.非结核分枝杆菌的环境风险。囊性纤维化人群中的个体暴露和气候因素。
Ann Am Thorac Soc. 2014 Sep;11(7):1032-8. doi: 10.1513/AnnalsATS.201404-184OC.
9
Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.囊性纤维化中非结核分枝杆菌的范式转变。
Respir Res. 2014 Apr 11;15(1):41. doi: 10.1186/1465-9921-15-41.
10
Pulmonary disease caused by Mycobacterium kansasii in a patient with cystic fibrosis.一名囊性纤维化患者罹患堪萨斯分枝杆菌所致的肺部疾病。
Pediatr Infect Dis J. 1997 Feb;16(2):257-9. doi: 10.1097/00006454-199702000-00021.
引用本文的文献
1
Ancillary treatment of patients with lung disease due to non-tuberculous mycobacteria: a narrative review.非结核分枝杆菌所致肺部疾病患者的辅助治疗：一项叙述性综述
J Thorac Dis. 2022 Sep;14(9):3575-3597. doi: 10.21037/jtd-22-410.
2
A Clinician's guide to vitamin D supplementation for patients with cystic fibrosis.囊性纤维化患者维生素D补充的临床医生指南
J Clin Transl Endocrinol. 2021 Nov 6;26:100273. doi: 10.1016/j.jcte.2021.100273. eCollection 2021 Dec.
本文引用的文献
1
The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.囊性纤维化基金会患者登记处。一个国家观察性疾病登记处的设计与方法。
Ann Am Thorac Soc. 2016 Jul;13(7):1173-9. doi: 10.1513/AnnalsATS.201511-781OC.
2
Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF).囊性纤维化（CF）患者中非结核分枝杆菌（NTM）的流行病学。
J Cyst Fibros. 2016 Sep;15(5):619-23. doi: 10.1016/j.jcf.2016.03.002. Epub 2016 Apr 1.
3
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.美国囊性纤维化基金会和欧洲囊性纤维化协会关于囊性纤维化患者非结核分枝杆菌管理的共识建议。
Thorax. 2016 Jan;71 Suppl 1(Suppl 1):i1-22. doi: 10.1136/thoraxjnl-2015-207360.
4
Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk.美国囊性纤维化患者中的非结核分枝杆菌：筛查实践与环境风险
Am J Respir Crit Care Med. 2014 Sep 1;190(5):581-6. doi: 10.1164/rccm.201405-0884OC.
5
Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.囊性纤维化患者首次非结核分枝杆菌培养阳性的临床意义
Ann Am Thorac Soc. 2014 Jan;11(1):36-44. doi: 10.1513/AnnalsATS.201309-310OC.
6
Severe vitamin D deficiency is associated with non-tuberculous mycobacterial lung disease: a case-control study.严重维生素 D 缺乏与非结核分枝杆菌肺病有关：一项病例对照研究。
Respirology. 2013 Aug;18(6):983-8. doi: 10.1111/resp.12109.
7
An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation.囊性纤维化患者维生素 D 缺乏的筛查、诊断、管理和治疗的最新进展：囊性纤维化基金会的循证推荐。
J Clin Endocrinol Metab. 2012 Apr;97(4):1082-93. doi: 10.1210/jc.2011-3050. Epub 2012 Mar 7.
8
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.维生素 D 缺乏的评估、治疗和预防：内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30. doi: 10.1210/jc.2011-0385. Epub 2011 Jun 6.
9
Vitamin d deficiency in cystic fibrosis.囊性纤维化中的维生素 D 缺乏。
Int J Endocrinol. 2010;2010:218691. doi: 10.1155/2010/218691. Epub 2010 Jan 28.
10
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.Toll样受体触发维生素D介导的人类抗菌反应。
Science. 2006 Mar 24;311(5768):1770-3. doi: 10.1126/science.1123933. Epub 2006 Feb 23.
Zotero 插件